Clinical Trial Update: Neo-adjuvant Chemoradiation With Oxaliplatin/5-FU in Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating neoadjuvant chemoradiation with oxaliplatin and 5-fluorouracil for rectal cancer. The study is completed, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (Adrucil) (5-Fluorouracil)
• Oxaliplatin (Eloxatin) (oxaliplatin)

Snippet

Sponsor: Beth Israel Medical Center | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-03-20